Michelle McMurry-Heath
CIK: 0001904156
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Jun 3, 2026BVS
Bioventus Inc.
Award(A)DirectRestricted Stock Units
25.1K shares- - Jun 2, 2026BVS
Bioventus Inc.
Exercise(M)Direct32.3K shares- - May 7, 2026RVTY
REVVITY, INC.
Award(A)Direct1.3K shares- - May 7, 2026RVTY
REVVITY, INC.
Award(A)Direct1K shares- - Mar 11, 2026BVS
Bioventus Inc.
Sale(S)Direct12K shares at avg. $8.79$105K - Feb 23, 2026RVTY
REVVITY, INC.
Sale(S)Direct600 shares at avg. $97.26$58K - Nov 7, 2025BVS
Bioventus Inc.
Sale(S)Direct17.7K shares at avg. $7.42$131K - Jun 3, 2025BVS
Bioventus Inc.
Award(A)DirectRestricted Stock Units
32.3K shares- - Jun 2, 2025BVS
Bioventus Inc.
Exercise(M)Direct26.5K shares- - May 29, 2025RVTY
REVVITY, INC.
Sale(S)Direct600 shares at avg. $92.17$55K - Apr 30, 2025RVTY
REVVITY, INC.
Award(A)Direct1.1K shares- - Apr 30, 2025RVTY
REVVITY, INC.
Award(A)Direct1.3K shares- - Feb 6, 2025RVTY
REVVITY, INC.
Sale(S)Direct2K shares at avg. $119.49$235K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 3, 2026 |  BVS Bioventus Inc. | Award(A) Restricted Stock Units | 25,146 | - | - | Direct |
| Jun 2, 2026 | BVS Bioventus Inc. | Exercise(M) | 32,282 | - | $0 | Direct |
| May 7, 2026 |  RVTY REVVITY, INC. | Award(A) | 1,265 | - | $0 | Direct |
| May 7, 2026 | RVTY REVVITY, INC. | Award(A) | 1,015 | - | $0 | Direct |
| Mar 11, 2026 | BVS Bioventus Inc. | Sale(S) | 12,000 | $8.79 | $105,439 | Direct |
| Feb 23, 2026 | RVTY REVVITY, INC. | Sale(S) | 600 | $97.26 | $58,356 | Direct |
| Nov 7, 2025 | BVS Bioventus Inc. | Sale(S) | 17,701 | $7.42 | $131,255 | Direct |
| Jun 3, 2025 | BVS Bioventus Inc. | Award(A) Restricted Stock Units | 32,282 | - | - | Direct |
| Jun 2, 2025 | BVS Bioventus Inc. | Exercise(M) | 26,493 | - | - | Direct |
| May 29, 2025 | RVTY REVVITY, INC. | Sale(S) | 600 | $92.17 | $55,299 | Direct |
| Apr 30, 2025 | RVTY REVVITY, INC. | Award(A) | 1,074 | - | - | Direct |
| Apr 30, 2025 | RVTY REVVITY, INC. | Award(A) | 1,338 | - | - | Direct |
| Feb 6, 2025 | RVTY REVVITY, INC. | Sale(S) | 1,970 | $119.49 | $235,395 | Direct |
1-13 of 13 transactions
About McMurry-Heath Michelle
McMurry-Heath Michelle (SEC CIK 0001904156) files insider reports with the SEC as Director of Bioventus Inc. (BVS) and Director of REVVITY, INC. (RVTY).
Signal8 holds 9 ownership filings by McMurry-Heath Michelle, all Form 4s, filed between Feb 7, 2025 and Jun 4, 2026. Those filings report 13 transactions, from Feb 6, 2025 to Jun 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on McMurry-Heath Michelle's filings is in DURHAM, NC.
Recent filings by McMurry-Heath Michelle
- Jun 3, 2026: Grant or award of BVS derivative securities (Form 4, code A).
- Jun 2, 2026: Option exercise of BVS shares (Form 4, code M).
- May 7, 2026: Grants or awards of RVTY shares (2 lines, Form 4, code A).
- Mar 11, 2026: Open-market sale of BVS shares (Form 4, code S).
- Feb 23, 2026: Open-market sale of RVTY shares (Form 4, code S).
Other insiders filing for Bioventus Inc. (BVS)
- Bartholdson John A., Director
- SUTTER MARTIN P, Director
- STALNECKER SUSAN M, Director
- NOHRA GUY P, Director
- NEELS GUIDO J, Director
- Ladone Mary Kay, Director